Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Chinese Patent Office
Cantor Fitzgerald

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for Patent: 6,106,848

« Back to Dashboard

Which drugs does patent 6,106,848 protect, and when does it expire?

Patent 6,106,848 protects CLOBEX and is included in one NDA. There have been three Paragraph IV challenges on Clobex.

This patent has twenty-six patent family members in twenty-one countries.

Summary for Patent: 6,106,848

Title: Topically applicable O/W emulsions having high glycol content and at least one biologically active agent
Abstract:Stable, topically applicable oil-in-water bioaffecting emulsions having intermediate viscosity, characteristically ranging from 3 to 10 Pa.multidot.s, comprise (a) from 30% to 50% by weight of at least one pro-penetrating glycol, (b) at least one emulsifying agent, advantageously an anionic amphiphilic polymer, and (c) at least one biologically active agent, for example an active agent that modulates skin differentiation and/or proliferation and/or pigmentation, an anti-inflammatory, an antibacterial, an antifungal, etc.
Inventor(s): Preuilh; Isabelle (Le Canet, FR), Willcox; Nathalie (Le Rouret, FR)
Assignee: Centre International de Recherches Dermatologiques (Valbonne, FR)
Application Number:08/935,054
Patent Claim Types:
see list of patent claims

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Galderma Labs LpCLOBEXclobetasol propionateLOTION;TOPICAL021535-001Jul 24, 2003ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 6,106,848

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France96 11510Sep 20, 1996

International Patent Family for Patent: 6,106,848

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina008637► Subscribe
Austria241960► Subscribe
Australia3758397► Subscribe
Australia695806► Subscribe
Brazil9702897► Subscribe
Canada2214909► Subscribe
Germany122006000024► Subscribe
Germany69722546► Subscribe
Denmark0832647► Subscribe
European Patent Office0832647► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Johnson and Johnson
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: